Dyspnoea score ‐ not measured · adults with acute exacerbations of chronic obstructive pulmonary disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Birthweight (g) · opiate‐dependent pregnant women
1 finding from 1 review
APGAR score (APGAR score ) · opiate‐dependent pregnant women
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events for the mother · opiate‐dependent pregnant women
1 finding from 1 review
Serious adverse events for the child · opiate‐dependent pregnant women
1 finding from 1 review
Unacceptability of treatment (dropouts/exclusions during the trial) · opiate‐dependent pregnant women
1 finding from 1 review
Use of substance · opiate‐dependent pregnant women
Methadone showed no clear difference in use of substance compared with oral slow‐release morphine (low certainty).
1 finding from 1 review
Cerebral palsy · preterm infants
1 finding from 1 review
Developmental delay at ≥ 18 months · preterm infants
1 finding from 1 review
Mortality during period of therapy · preterm infants
Moderate showed no clear difference in mortality during the intervention period compared with low protein concentration of human milk fortifier; GRADE not reported.
1 finding from 1 review
Rate of weight gain (g/kg/day) · preterm infants
1 finding from 1 review
Linear growth (cm/week) · preterm infants
1 finding from 1 review
Growth: head circumference (cm/week) · preterm infants
1 finding from 1 review
Miscarriage · couples undergoing embryo transfer
High showed no clear difference in miscarriage rate compared with low or no hyaluronic acid (low certainty).
1 finding from 1 review
Multiple pregnancy rate · couples undergoing embryo transfer
High probably leads to higher multiple pregnancy rate compared with low or no hyaluronic acid (moderate certainty).
1 finding from 1 review
Adverse event rate · couples undergoing embryo transfer
High showed no clear difference in adverse event rate compared with low or no hyaluronic acid (low certainty).
1 finding from 1 review
Uterine fibroid‐related symptoms (abnormal uterine bleeding, measured at 12 weeks, with the pictorial blood assessment chart (PBAC); lower = better) · women with uterine fibroids
2 findings from 1 review
Haemoglobin level ‐ Haemoglobin level at 12 months Scale from: 0 to 20. · women with uterine fibroids
1 finding from 1 review
Fibroid size · women with uterine fibroids
1 finding from 1 review
Adverse events · women with uterine fibroids
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found